Cargando…

Prevalence of Epstein–Barr virus (EBV) in Iranian Breast Carcinoma Patients

INTRODUCTION: Breast cancer (BC) is the most common malignancy affecting females worldwide. Various risk factors play a role in the developing of BC. Infectious agents like viruses have been proposed for this cancer and Epstein-Barr virus (EBV) is a widely researched candidate virus. This study dete...

Descripción completa

Detalles Bibliográficos
Autores principales: Golrokh Mofrad, Morvarid, Kazeminezhad, Behrang, Faghihloo, Ebrahim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294004/
https://www.ncbi.nlm.nih.gov/pubmed/31983175
http://dx.doi.org/10.31557/APJCP.2020.21.1.133
_version_ 1783546393976111104
author Golrokh Mofrad, Morvarid
Kazeminezhad, Behrang
Faghihloo, Ebrahim
author_facet Golrokh Mofrad, Morvarid
Kazeminezhad, Behrang
Faghihloo, Ebrahim
author_sort Golrokh Mofrad, Morvarid
collection PubMed
description INTRODUCTION: Breast cancer (BC) is the most common malignancy affecting females worldwide. Various risk factors play a role in the developing of BC. Infectious agents like viruses have been proposed for this cancer and Epstein-Barr virus (EBV) is a widely researched candidate virus. This study detects the presence of EBV-DNA in breast cancer patients. METHODS: The study was conducted on 59 formalin-fixed paraffin-embedded (FFPE) tissue blocks samples of women with breast carcinoma and 11 non-neoplastic breast controls. The DNA was extracted for all the samples. Then detection of EBNA1 EBV was done by polymerase chain reaction (PCR). RESULTS: EBV was detected in 6.7% (4/59) of patients while all breast control samples were negative. All patients with positive EBV-DNA were high tumor grades (II, and III). Also, they had a low level of educations. CONCLUSIONS: According to our findings, it can be suggested that EBV may have a potential role in breast cancer development. However, this study provides substantial but not conclusive evidence for the involvement of viruses in BC disease development. Therefore, future investigations are needed to elucidate the exact role of EBV in breast cancer.
format Online
Article
Text
id pubmed-7294004
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher West Asia Organization for Cancer Prevention
record_format MEDLINE/PubMed
spelling pubmed-72940042020-06-29 Prevalence of Epstein–Barr virus (EBV) in Iranian Breast Carcinoma Patients Golrokh Mofrad, Morvarid Kazeminezhad, Behrang Faghihloo, Ebrahim Asian Pac J Cancer Prev Research Article INTRODUCTION: Breast cancer (BC) is the most common malignancy affecting females worldwide. Various risk factors play a role in the developing of BC. Infectious agents like viruses have been proposed for this cancer and Epstein-Barr virus (EBV) is a widely researched candidate virus. This study detects the presence of EBV-DNA in breast cancer patients. METHODS: The study was conducted on 59 formalin-fixed paraffin-embedded (FFPE) tissue blocks samples of women with breast carcinoma and 11 non-neoplastic breast controls. The DNA was extracted for all the samples. Then detection of EBNA1 EBV was done by polymerase chain reaction (PCR). RESULTS: EBV was detected in 6.7% (4/59) of patients while all breast control samples were negative. All patients with positive EBV-DNA were high tumor grades (II, and III). Also, they had a low level of educations. CONCLUSIONS: According to our findings, it can be suggested that EBV may have a potential role in breast cancer development. However, this study provides substantial but not conclusive evidence for the involvement of viruses in BC disease development. Therefore, future investigations are needed to elucidate the exact role of EBV in breast cancer. West Asia Organization for Cancer Prevention 2020 /pmc/articles/PMC7294004/ /pubmed/31983175 http://dx.doi.org/10.31557/APJCP.2020.21.1.133 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Golrokh Mofrad, Morvarid
Kazeminezhad, Behrang
Faghihloo, Ebrahim
Prevalence of Epstein–Barr virus (EBV) in Iranian Breast Carcinoma Patients
title Prevalence of Epstein–Barr virus (EBV) in Iranian Breast Carcinoma Patients
title_full Prevalence of Epstein–Barr virus (EBV) in Iranian Breast Carcinoma Patients
title_fullStr Prevalence of Epstein–Barr virus (EBV) in Iranian Breast Carcinoma Patients
title_full_unstemmed Prevalence of Epstein–Barr virus (EBV) in Iranian Breast Carcinoma Patients
title_short Prevalence of Epstein–Barr virus (EBV) in Iranian Breast Carcinoma Patients
title_sort prevalence of epstein–barr virus (ebv) in iranian breast carcinoma patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294004/
https://www.ncbi.nlm.nih.gov/pubmed/31983175
http://dx.doi.org/10.31557/APJCP.2020.21.1.133
work_keys_str_mv AT golrokhmofradmorvarid prevalenceofepsteinbarrvirusebviniranianbreastcarcinomapatients
AT kazeminezhadbehrang prevalenceofepsteinbarrvirusebviniranianbreastcarcinomapatients
AT faghihlooebrahim prevalenceofepsteinbarrvirusebviniranianbreastcarcinomapatients